675 articles in this topic
A real-world study of 37,000+ matched patients finds GLP-1 receptor agonists dramatically reduce cardiovascular events in obese adults with OSA.
A new meta-analysis of 37,393 patients finds GLP-1 receptor agonists may reduce mortality and major cardiac events in type 2 diabetics with prior MI.
After meals, bacterial toxins leaking into the bloodstream raise the odds of a second heart attack. The Mediterranean diet outperforms low-fat diets in blunting this threat.
A massive meta-analysis of 51 trials finds BP-lowering drugs deliver cardiovascular protection fast — and don't compound over time.
EASIX — calculated from creatinine, LDH, and platelets — independently predicts mortality in over 3,200 coronary artery disease patients.
A mechanosensitive ion channel fuels arteriovenous malformations in a hereditary bleeding disorder — and blocking it reduces AVM formation in mice.
A transcription factor in endothelial cells declines with age and its loss drives fibrosis, hypertrophy, and diastolic dysfunction — but restoring it reverses damage.
A completed Montreal trial tested remote physical and cognitive training in 122 older adults with cardiovascular disease.
A completed University of Florida trial probes why aerobic exercise improves artery function in older men but yields inconsistent results in postmenopausal women.
Simon Hill ranks 8 popular supplements by human evidence for reversing atherosclerosis — one stands far above the rest.
A forensic autopsy study of 112 individuals found no correlation between omega-3 status and coronary artery stenosis — but the population's omega-3 index was dangerously low.
AHA, ACC, ESC, and WHF release a landmark 2026 consensus redefining heart failure staging and classification worldwide.
